CDA-AMC

On September 5th, 2024, Katherine Scott and Lana Duan from MORSE Consulting presented “Accelerating Access: Leveraging Target Zero to Expedite Time to Access for New Therapies” at the CDA-AMC Symposium. They explored how pre-NOC submissions impact market access timelines, using CDA-validated data and insights from our internal database.Download our presentation to learn more about these findings and strategies for accelerating access to new therapies. Panelists We'd like to thank all…